158 related articles for article (PubMed ID: 2306831)
41. In vivo induction of "focal" triggered ventricular arrhythmias and responses to overdrive pacing in the canine heart.
Furukawa T; Kimura S; Catstellanos A; Bassett AL; Myerburg RJ
Circulation; 1990 Aug; 82(2):549-59. PubMed ID: 2372901
[TBL] [Abstract][Full Text] [Related]
42. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
[TBL] [Abstract][Full Text] [Related]
43. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
44. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
45. Characterization of oscillations in ventricular refractoriness in man after an abrupt increment in heart rate.
Marchlinski FE
Circulation; 1987 Mar; 75(3):550-6. PubMed ID: 3815767
[TBL] [Abstract][Full Text] [Related]
46. Electrocardiographic signal-averaging during atrial pacing and effect of cycle length on the terminal QRS in patients with and without inducible ventricular tachycardia.
Kremers MS; Black WH; Lange R; Wells PJ; Solo M
Am J Cardiol; 1990 Nov; 66(15):1095-8. PubMed ID: 2220637
[TBL] [Abstract][Full Text] [Related]
47. Strength-interval curves in canine myocardium at very short cycle lengths.
Alferness C; Bayly PV; Krassowska W; Daubert JP; Smith WM; Ideker RE
Pacing Clin Electrophysiol; 1994 May; 17(5 Pt 1):876-81. PubMed ID: 7517522
[TBL] [Abstract][Full Text] [Related]
48. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
49. Modulation of quinidine-induced arrhythmias by temperature in perfused rabbit heart.
Spear JF; Moore EN
Am J Physiol; 1998 Mar; 274(3):H817-28. PubMed ID: 9530193
[TBL] [Abstract][Full Text] [Related]
50. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
51. The electrophysiologic effects of quinidine in the transplanted human heart.
Mason JW; Winkle RA; Rider AK; Stinson EB; Harrison DC
J Clin Invest; 1977 Mar; 59(3):481-9. PubMed ID: 320227
[TBL] [Abstract][Full Text] [Related]
52. Comparison of ventricular refractory periods determined by incremental and decremental scanning of an extrastimulus.
Morady F; Kadish AH; Kushner JA; Toivonen LK; Schmaltz S
Pacing Clin Electrophysiol; 1989 Apr; 12(4 Pt 1):546-54. PubMed ID: 2470036
[TBL] [Abstract][Full Text] [Related]
53. The effects of procainamide on conduction in anisotropic canine ventricular myocardium.
Kadish AH; Spear JF; Levine JH; Moore EN
Circulation; 1986 Sep; 74(3):616-25. PubMed ID: 3742759
[TBL] [Abstract][Full Text] [Related]
54. Changes in cardiac repolarization following short periods of ventricular pacing.
Goyal R; Syed ZA; Mukhopadhyay PS; Souza J; Zivin A; Knight BP; Man KC; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 1998 Mar; 9(3):269-80. PubMed ID: 9554732
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of intravenous quinidine.
Swerdlow CD; Yu JO; Jacobson E; Mann S; Winkle RA; Griffin JC; Ross DL; Mason JW
Am J Med; 1983 Jul; 75(1):36-42. PubMed ID: 6859083
[TBL] [Abstract][Full Text] [Related]
56. Is the adaptation of right ventricular refractoriness to an abrupt increase in heart rate impaired in chronic heart failure?
Denardo SJ; Stevenson WG
Am Heart J; 1989 Mar; 117(3):585-9. PubMed ID: 2465681
[TBL] [Abstract][Full Text] [Related]
57. Cumulative effects of cycle length on ventricular refractoriness in man.
Brownstein SL; Blackwell WH; Welch WJ; Bauernfeind RA
Am Heart J; 1990 Feb; 119(2 Pt 1):324-30. PubMed ID: 2301221
[TBL] [Abstract][Full Text] [Related]
58. Prolongation of the human cardiac monophasic action potential by sotalol.
Echt DS; Berte LE; Clusin WT; Samuelsson RG; Harrison DC; Mason JW
Am J Cardiol; 1982 Nov; 50(5):1082-6. PubMed ID: 6127944
[TBL] [Abstract][Full Text] [Related]
59. Effect of right ventricular pacing site on QRS width.
Nakamura H; Mine T; Kanemori T; Ohyanagi M; Masuyama T
Asian Cardiovasc Thorac Ann; 2011 Oct; 19(5):339-45. PubMed ID: 22100929
[TBL] [Abstract][Full Text] [Related]
60. Relationship between beat-to-beat changes in hemodynamic state and action potential duration of the left ventricle during rapid ventricular pacing in man.
Huikuri HV; Peuhkurinen KJ; Takkunen JT
Pacing Clin Electrophysiol; 1992 Jun; 15(6):878-85. PubMed ID: 1376900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
